X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20833) 20833
Magazine Article (104) 104
Book / eBook (12) 12
Newsletter (11) 11
Conference Proceeding (9) 9
Book Chapter (7) 7
Web Resource (6) 6
Dissertation (4) 4
Government Document (3) 3
Publication (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19348) 19348
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (17003) 17003
male (10289) 10289
female (9373) 9373
statins (7663) 7663
middle aged (7594) 7594
aged (6719) 6719
risk factors (4921) 4921
cardiac & cardiovascular systems (4038) 4038
cholesterol (3944) 3944
treatment outcome (3815) 3815
adult (3693) 3693
animals (3074) 3074
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (3047) 3047
pharmacology & pharmacy (2991) 2991
cholesterol, ldl - blood (2960) 2960
simvastatin (2947) 2947
atorvastatin (2895) 2895
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (2721) 2721
risk (2714) 2714
medicine, general & internal (2519) 2519
cardiovascular diseases - prevention & control (2512) 2512
hypercholesterolemia - drug therapy (2446) 2446
prevention (2422) 2422
anticholesteremic agents - therapeutic use (2259) 2259
therapy (2145) 2145
atherosclerosis (2139) 2139
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (2055) 2055
mortality (2037) 2037
peripheral vascular disease (2022) 2022
pravastatin (1950) 1950
aged, 80 and over (1949) 1949
abridged index medicus (1935) 1935
cardiovascular disease (1929) 1929
coronary-heart-disease (1850) 1850
lipids (1764) 1764
retrospective studies (1663) 1663
atorvastatin calcium (1634) 1634
statin (1622) 1622
heptanoic acids - therapeutic use (1585) 1585
cardiovascular diseases (1578) 1578
time factors (1570) 1570
pyrroles - therapeutic use (1565) 1565
drug therapy, combination (1541) 1541
care and treatment (1540) 1540
cholesterol - blood (1535) 1535
analysis (1522) 1522
drug therapy (1514) 1514
simvastatin - therapeutic use (1481) 1481
cardiovascular (1465) 1465
disease (1441) 1441
research (1412) 1412
hypolipidemic agents - therapeutic use (1391) 1391
hypercholesterolemia (1372) 1372
myocardial-infarction (1364) 1364
randomized controlled trials as topic (1363) 1363
risk assessment (1354) 1354
cardiovascular-disease (1336) 1336
prospective studies (1334) 1334
c-reactive protein (1314) 1314
inflammation (1310) 1310
dyslipidemias - drug therapy (1303) 1303
follow-up studies (1269) 1269
cardiovascular agents (1175) 1175
hyperlipidemias - drug therapy (1173) 1173
lipids - blood (1159) 1159
metaanalysis (1155) 1155
health aspects (1153) 1153
hydroxymethylglutaryl-coa reductase inhibitors (1130) 1130
coronary heart disease (1126) 1126
cholesterol, hdl - blood (1097) 1097
medicine & public health (1085) 1085
practice guidelines as topic (1068) 1068
biomarkers - blood (1063) 1063
primary prevention (1061) 1061
internal medicine (1060) 1060
diabetes (1054) 1054
rosuvastatin (1050) 1050
double-blind method (1038) 1038
rosuvastatin calcium (1033) 1033
secondary prevention (1023) 1023
cohort studies (1017) 1017
cardiology (997) 997
clinical trials as topic (992) 992
low density lipoproteins (976) 976
triglycerides - blood (975) 975
events (974) 974
statin therapy (932) 932
dose-response relationship, drug (921) 921
angiotensin-converting enzyme inhibitors - therapeutic use (913) 913
pravastatin - therapeutic use (901) 901
platelet aggregation inhibitors - therapeutic use (876) 876
coronary disease - prevention & control (871) 871
rats (871) 871
stroke (861) 861
cardiovascular diseases - drug therapy (855) 855
surgery (855) 855
fluorobenzenes - therapeutic use (854) 854
coronary artery disease - drug therapy (853) 853
hypercholesterolemia - blood (853) 853
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19844) 19844
German (290) 290
Japanese (241) 241
Spanish (232) 232
French (222) 222
Russian (114) 114
Italian (95) 95
Chinese (72) 72
Portuguese (57) 57
Polish (56) 56
Hungarian (43) 43
Czech (40) 40
Dutch (36) 36
Swedish (28) 28
Turkish (25) 25
Danish (19) 19
Finnish (16) 16
Norwegian (12) 12
Ukrainian (10) 10
Serbian (9) 9
Hebrew (7) 7
Croatian (6) 6
Romanian (6) 6
Bosnian (3) 3
Korean (2) 2
Lithuanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
Summary Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary prevention medications in these communities... 
Internal Medicine | STROKE | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | THERAPY | MYOCARDIAL-INFARCTION | AVAILABILITY | HEART-FAILURE | SELF-REPORT | ACUTE CORONARY SYNDROMES | MEDICINES | VALIDITY | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 372, Issue 25, pp. 2387 - 2397
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 12, pp. 1091 - 1099
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10013, pp. 61 - 69
...% of communities and used by 50% of eligible individuals by 2025. We have previously reported that use of these medicines is very low, but now aim to assess how such low use relates to their lack of availability or poor affordability... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | Drug Costs | Platelet Aggregation Inhibitors - economics | Cardiovascular Diseases - drug therapy | Humans | Income | Malaysia | Secondary Prevention | Aspirin - supply & distribution | Urban Population | Angiotensin-Converting Enzyme Inhibitors - supply & distribution | Angiotensin-Converting Enzyme Inhibitors - economics | Sweden | Pakistan | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Iran | Rural Population | China | Adrenergic beta-Antagonists - economics | Brazil | Poland | Aspirin - therapeutic use | Aspirin - economics | Chile | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Cardiovascular Agents - economics | Colombia | Argentina | Platelet Aggregation Inhibitors - supply & distribution | Hydroxymethylglutaryl-CoA Reductase Inhibitors - supply & distribution | Hydroxymethylglutaryl-CoA Reductase Inhibitors - economics | United Arab Emirates | Adrenergic beta-Antagonists - supply & distribution | India | Pharmacies | Canada | Cardiovascular Agents - supply & distribution | Cardiovascular Agents - therapeutic use | Bangladesh | Family Characteristics | Developed Countries | Turkey | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | South Africa | Zimbabwe | Developing Countries | Drugs | Prevention | Usage | Cardiovascular diseases | Analysis | Disease prevention | Cardiovascular disease | Costs | Health care access | Preventive medicine | Health risk assessment | Klinisk medicin | Clinical Medicine
Journal Article
Pharmacology & therapeutics (Oxford), ISSN 0163-7258, 2014, Volume 143, Issue 1, pp. 87 - 110
.... The enzyme 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase (HMGCR) is the rate-limiting step in cholesterol biosynthesis and catalyzes the conversion of HMG-CoA to MVA... 
Farnesyl transferase inhibitors | Rho GTPase | Statins | Fibrosis | Asthma | Geranylgeranyl transferase inhibitors | C-REACTIVE PROTEIN | SMALL GTPASE RHOA | BRONCHIAL EPITHELIAL-CELLS | COENZYME-A REDUCTASE | GERANYLGERANYLTRANSFERASE-I INHIBITOR | HMG-COA REDUCTASE | RHO-KINASE INHIBITOR | RANDOMIZED CONTROLLED-TRIAL | PHARMACOLOGY & PHARMACY | SMOOTH-MUSCLE-CELLS | NF-KAPPA-B | rho-Associated Kinases - physiology | rho GTP-Binding Proteins - antagonists & inhibitors | Cardiovascular Diseases - drug therapy | Humans | Alkyl and Aryl Transferases - antagonists & inhibitors | Hydroxymethylglutaryl CoA Reductases - physiology | Lung Diseases - drug therapy | Mevalonic Acid - metabolism | rho GTP-Binding Proteins - physiology | rho-Associated Kinases - antagonists & inhibitors | Neoplasms - drug therapy | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Farnesyltranstransferase - antagonists & inhibitors | Pulmonary Disease, Chronic Obstructive - drug therapy | Enzymes | Hypercholesterolemia | Lung diseases | Physiological aspects | Cardiovascular diseases | Health aspects | Cancer | geranylgeranyl transferase inhibitors | farnesy transferase inhibtors | asthma | fibrosis | cancer | chronic obstructive pulmonary disease
Journal Article
Cochrane library, ISSN 1465-1858, 2014, Volume 2014, Issue 7, pp. CD007784 - CD007784
Journal Article